Deadly fungal infections are becoming resistant to common treatments, but a team of researchers from USC and from France have found a potential innovative solution.
Each year, invasive fungal infections sicken an estimated 2 million people worldwide and kill nearly 800,000 – but a team of international scientists have discovered a new approach for antifungal drug treatments.
Researchers from USC and France identified that a gene-regulating protein, Bdf1, is critical for the survival of the pathogenic fungus, Candida albicans.
“We have shown that Bdf1 is an important new target for drug design,” said Charles McKenna, a senior author of the study who is a professor of chemistry and pharmaceutical sciences in the USC Dornsife College of Letters, Arts and Sciences. “Our findings show that compounds that bind to this target will disrupt the growth of the fungus, opening the way to novel drug treatments for fungal disease.”
The French scientists who led the study with McKenna were Jérôme Govin and Carlo Petosa, both at the University of Grenoble Alpes.
Rising health threat
The fungus, C. albicans, is an aggressive pathogen that in healthy individuals is normally held in check by the immune system. However, people with a weakened immune system, including patients who have cancer, HIV or autoimmune diseases, are susceptible to the infection, which can be life-threatening, McKenna said.
The team’s findings, published on May 18 in the journal Nature Communications, may prove timely. Fungal infections such as candidiasis are increasingly resistant to drug treatments.
Each year, an estimated 46,000 patients in the United States become infected with invasive candidiasis, according to the Centers for Disease Control and Prevention.
“When susceptible people develop candida infections, the fungus may enter the bloodstream. If treatment is unsuccessful, it has a very high mortality rate – in the 40 percent range,” McKenna said. “We have a very limited number of drugs that are effective in treating such systemic infections. Unfortunately, like many other pathogens, C. albicans is increasingly resistant to the few available drugs, raising the stakes for patients, and fresh approaches are urgently needed.”
The Latest on: Antifungal drug treatments
- Asia-Pacific Antifungal Drugs Market Segment-level analysis Report on August 20, 2017 at 11:48 pm
Browse market data tables and in-depth TOC of the Asia-Pacific Antifungal Drugs Market to 2021 @ www.marketdataforecast.com/market-reports/asia-pacific-anti-fung .. Antifungal drugs are used to cure fungal infections which are usually caused by unclean ... […]
- Antifungal Drugs Market to Register Substantial Expansion by 2024 on August 18, 2017 at 6:42 am
There are different types of antifungal medicines such as topical antifungals which are mostly applied on the skin, nails or hair, secondly there are oral antifungals which are consumed or swallowed in capsule, liquid form or pill and last is intravenous ... […]
- Comprehensive analysis of global antifungal drugs market made available by top research firm on August 14, 2017 at 2:05 am
Europe Antifungal Drugs Market which is estimated to be USD 3.16 billion in 2016 and expected to grow at a CAGR of 3.4%, to reach USD 3.73 billion by 2021 with a cumulative growth rate of USD 0.57 billion in the span of five years. It can attributed to the ... […]
- Asia-Pacific Anti-Fungal Drugs Market estimated to reach $2.38 billion by 2021 with a CAGR of 4.1% on August 11, 2017 at 8:46 am
(EMAILWIRE.COM, August 11, 2017 ) There are several types of antifungal medicines. They come as creams, sprays, solutions, tablets designed to go into the vagina, shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of ... […]
- Global Antifungal Treatment Market 2022 - by Medicine, Application and Region on August 11, 2017 at 8:15 am
Request a Sample Report @ https://www.marketresearchfuture.com/sample_request/1628 However factors that may affect the market growth mainly include patient or practitioners’ scepticism towards antifungal drugs, generics prescriptions and government ... […]
- Antifungal Drugs Market Estimated to Flourish by 2024 on August 10, 2017 at 4:50 am
Antifungal drugs medication is done for treating fungal infections with minimal side effects on the body. Basically this fungal infections are organism that feed by breaking down the living tissue these fungi are commonly known as dermatophytes ... […]
- Antifungal Treatment Global Market Predicted To Perceive Promising Growth By 2023 on August 8, 2017 at 5:27 am
However factors that may affect the market growth mainly include patient or practitioners’ scepticism towards antifungal drugs, generics prescriptions and government regulations in pharmaceutical industry and allergic reaction to some types of anti ... […]
- Antifungal Drugs Market by Drug Type, Infection Type, Dosage Form and Therapeutic Indication on July 6, 2017 at 6:37 am
According to a new report published by Allied Market Research, titled, "Antifungal Drugs Market by Drug type, Infection type, Indication, and Dosage Forms: Global Opportunity Analysis and Industry Forecast, 2017-2023," the global market was valued at $ ... […]
- Antifungal Drugs Market 2017– Future Growth, Opportunities and Forecast To 2021 on May 18, 2017 at 3:32 am
The Global Antifungal Drugs Market to Grow at a CAGR of 3.20% during the period 2017-2021. Antifungal Drugs Market Report focuses on the major drivers and restraints for the key players. These Research Report also provides granular analysis of the market ... […]
- Antifungal Drugs: Technologies and Global Markets on March 13, 2017 at 10:28 am
NEW YORK, March 13, 2017 /PRNewswire/ -- Use this report to: - Evaluate the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. - Investigate the current market dynamics and factors ... […]
via Google News and Bing News